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Introduction. Actinomycosis is a chronic bacterial infection caused by Actinomyces, Gram-positive anaerobic bacteria. Its symp-
tomatology imitates some malignant pelvic tumours, tuberculosis, or nocardiosis, causing abscesses and fistulas. Actinomycoses
are opportunistic infections and require normal mucous barriers to be altered. No epidemiological studies have been conducted
to determine prevalence or incidence of such infections. Objective. To analyse the clinical cases of pelvic actinomycosis reported
worldwide, to update the information about the disease. Methods. A systematic review of worldwide pelvic actinomycosis cases
between 1980 and 2014 was performed, utilising the PubMed, Scopus, and Google Scholar databases. The following information
was analysed: year, country, type of study, number of cases, use of intrauterine device (IUD), final and initial diagnosis, andmethod
of diagnosis. Results. 63 articles met the search criteria, of which 55 reported clinical cases and 8 reported cross-sectional studies.
Conclusions. Pelvic actinomycosis is confusing to diagnose and should be considered in the differential diagnosis of pelvic chronic
inflammatory lesions. It is commonly diagnosed through a histological report, obtained after a surgery subsequent to an erroneous
initial diagnosis. A bacterial culture in anaerobic medium could be useful for the diagnosis but requires a controlled technique and
should be performed using specialised equipment.
1. Introduction
Actinomycosis is a chronic bacterial infection, suppurative
and granulomatous in nature, caused by bacteria of the genus
Actinomyces [1], a group of Gram-positive anaerobic bacteria
that form filamentous microcolonies [2], do not form spores,
measure up to 1𝜇m diameter, and are slow-growing [1]. Acti-
nomycosis is an uncommon condition whose symptomatol-
ogy imitates somemalignant pelvic tumours, tuberculosis, or
nocardiosis because it spreads progressively and continuously
[3]. This pathology invades tissue layers, causing the forma-
tion of abscesses and fistulae. Its diagnosis is difficult, and
it results in increased morbimortality. Actinomyces belong to
the phylum Actinobacteria and to the order Actinomycetales.
Hundreds ofActinomyces species exist, most of which inhabit
the soil. Others are associated with plants, which participate
in nitrogen fixation, and a few species live in human beings
as saprophytic bacteria [2]. It should be highlighted that most
Actinomyces spp. are present inmicrobiota, chiefly inhabiting
the oropharynx, gastrointestinal tract, and urogenital tract
[3].
Actinomycoses are opportunistic chronic infections [4],
as Actinomyces have a low potential for virulence in connec-
tion with fimbriae. Therefore, they require normal mucosal
barriers to be altered through trauma, surgery, or an infec-
tion. In this way, they cross the mucosal membrane or
epithelial surface [4–6]. For example, a pulmonary infection
can be caused by bronchoaspiration [5, 7], or a pelvic
infection can originate from the use of an intrauterine device
(IUD), which can injure or perforate the mucosal membrane
of the uterus and facilitate infection [3].
Currently, various clinical characteristics of actinomyco-
sis have been described, and the bacteriumhas been observed
in various anatomical sites (e.g., face, bones and articulations,
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respiratory tract, urogenital tract, digestive tract, central
nervous system, skin, and soft tissue structures). The most
frequent clinical form of the disease is cervicofacial acti-
nomycosis, representing approximately 60% of all reported
cases, and is associated with odontogenic infection. Other
clinical types include thoracic actinomycosis, the third most
common type of actinomycosis, which includes pulmonary,
bronchial, and laryngeal actinomycosis [3], and abdominal
actinomycosis, where the appendix, caecum, and colon are
the most common sites of infection. Actinomycosis of the
central nervous system is located chiefly in the cerebral
abscess. Actinomycosis of the urogenital tract is the second
most common clinical form of actinomycosis, and the prin-
cipal clinical presentation is pelvic actinomycosis [3, 5, 8].
Pelvic actinomycosis can affect any age group, with no
preference for occupation or season and is secondary to
perforation or fistulation [4]. Other possible causes include
bacterial vaginosis, which fosters an anaerobic environment
and is associated with other microorganisms [51]; the pres-
ence of tumours [66]; and the use of IUDs [3–5]. The pos-
sibility of a contagion through oral sex has been considered
because these bacteria are part of the oral cavity microbiota
[72]. One possible route of dissemination is through IUDs,
which fosters the growth of microorganisms through wires
that are left in the exocervix. In addition, the IUD changes the
carbohydrate metabolism in endometrial cells, fostering still
more inflammation. Another probable route is the perineum,
where the microorganisms could extend from the anus up
through the cervicovaginal zone [4].
The most common aetiological agent is Actinomyces
israelii [5, 73]. Other reported species include A. naeslundii,
A. viscosus, A. odontolyticus, A. pyogenes, A. urogenitalis, and
A. turicensis [72, 74, 75].
The symptoms of pelvic actinomycosis associated with
the use of an IUD can imitate symptoms of gynaecological
malignant tumours, uterine myoma, or adenomyosis when
presenting as a genital mass without fever [3]. The infection
can disseminate to the uterine tubes and can cause salpingitis
and the subsequent destruction of the ovarian parenchyma
[4]. Organs such as the bladder, ileocaecal (iliac fossa) and
rectosigmoid region, colon, urethra, and extension to the skin
have been reportedly affected in various published cases.
The diagnosis of pelvic actinomycosis is obtained using
various techniques because culturing Actinomyces spp.
presents difficulties and also depends on the skill and access
to equipment necessary to perform it.
(a) First, the signs and symptoms of the patients are
considered and can point to a possible abdomi-
nal infection, vaginitis, abscess, or possible tumour-
forming process. The most common symptoms are
weight loss, nonspecific abdominal or pelvic pain,
breakthrough bleeding or abundant vaginal flow, and,
on rare occasions, fever [3, 4, 51].
(b) Upon medical exploration, the affected zone is pal-
pated to detect hard masses, and a gynaecological
exam is performed to check for inflammation of the
vaginal mucous membrane, yellowish secretion with
a bad smell, or some visible damage to the mucous
membrane [4, 51].
(c) In laboratory studies, it is possible to identify leuco-
cytosis, erythropaenia, and high sedimentation rate;
high values of C-reactive protein; and tumourmarker
values within the reference ranges or slightly elevated
like Ca 125 (Alpha-fetoprotein), and cancer antigen
15–3 [3, 4, 51].
(d) Diagnostic images, such as computed tomogra-
phy, magnetic resonance, ultrasound, X-rays, and
laparoscopy are helpful, as they can be used to observe
the affected zone, such as a tumour-formingmass that
can induce either actinomycosis or a carcinogenic
process [4, 51, 73].
(e) In most cases, histological visualisation of biopsy or
aspirated samples is employed, where bacilli in the
tissuewith their typical ramifications, such as in inter-
connected breasts, are observed. Cervicovaginal cells
are collected for Papanicolaou (Pap) staining. In both
cases, they are reported as Microorganisms Similar
to Actinomyces (MSA) [4, 51]. In many cases, the
diagnosis is made a posteriori through a histological
examination of samples obtained surgically during
laparotomy or laparoscopy, but rarely in a preop-
erative manner. Histological studies of tissues show
inflammatory changes of suppurative and granulo-
matous nature, connective proliferation, and sulphur
granules, which have also been identified in infec-
tions caused by Nocardia brasiliensis, Actinomadura
madurae, and Staphylococcus aureus. These granules
are particles of yellowish colour, which, when viewed
by the naked eye, are formed by groups of filamentous
Actinomyces surrounded by neutrophils [73].
(f) Two methods exist for completely identifying the
causal agent: culture and identification through bio-
chemical tests and identification through sequenc-
ing of the 16S rRNA segment, which offers greater
precision. Although these methods are very efficient,
they are not well reported in the literature due to
the conditions under which they must be performed,
requiring an anaerobic culture environment and the
necessary equipment, which is costly.
The usual treatment for actinomycosis consists of high
and prolonged doses of penicillin G (20 million units per
day) or amoxicillin for 4 to 6 weeks, followed by penicillin
V (4 g per day) orally for 6 to 12 months. Clindamycin,
tetracycline, and erythromycin are an alternative in cases of
allergy to penicillin [4, 5]. In addition to these medicines, it
has been observed that Actinomyces is also sensitive to third-
generation cephalosporins, ciprofloxacin, trimethoprim-sul-
famethoxazole, and rifampicin [4]. However, the elimination
of the injured tissue and surgical drainage are necessary mea-
sures in some cases [5], and, in these patients, the duration of
antimicrobial therapy could be reduced (3 months) [3].
In the review performed byMart´ınez et al. [74], it is men-
tioned that there are reports of the presence ofActinomyces in
secretions starting from 1877, recorded by Harz. Beedham et
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Figure 1: Search strategy: flow chart of literature research.
al. found that the first reports of intrauterine actinomycosis
related to IUDs appeared in the 1920s [76]. Clinical cases of
pelvic actinomycosis have been reported in Africa, Oceania,
Asia, Europe, and America. However, as pelvic actinomycosis
is an uncommon infection, no epidemiological studies have
been conducted to determine its prevalence or incidence.
2. Materials and Methods
We performed this analysis according to the guidelines of
the Meta-Analysis of Observational Studies in Epidemiol-
ogy Group (MOOSE). A systematic review of worldwide
cases of pelvic actinomycosis between the years 1980 and
2014 was performed. Studies that described clinical cases of
pelvic actinomycosis with a detailed diagnostic method and
cross-sectional studies of cases of actinomycosis available in
the PubMed, Scopus, and Google Scholar databases were
included using the following keywords: Pelvic actinomy-
cosis, Actinomycosis pe´lvica, “Actinomycosis prevalence”,
“Prevalencia de actinomycosis”, “Actinomyces” AND “female
genital tract” and combinations of these terms. The use of
quotes was avoided when searching for the terms Pelvic
actinomycosis andActinomycosis pe´lvica in order to increase
the search results.
Abstracts of articles identified to be relevant for the
objective of this paper were read; studies whose abstract or
full text was unavailable were automatically excluded. When
an abstract complied with inclusion criteria, the full text was
analysed. Case reports that lacked a diagnostic method and a
final diagnosis of pelvic actinomycosis were excluded. Studies
published in a language thatwas not English, Spanish, French,
or Portuguese were not included. The following information
was extracted and analysed from the compiled studies: year,
country, type of study, number of cases, prior use of IUD and
duration, initial diagnosis, treatment, definitive diagnosis,
and method of definitive diagnosis (Figure 1).
3. Results
The search yielded a total of 3852 studies; 3693 were excluded
from the title, abstract, and language screening; 96more were
excluded for not being available in full text format and for not
meeting the selection criteria when reading the full article.
A total of 63 studies including 86 case reports of pelvic
actinomycosis, along with 8 cross-sectional studies of reports
examining populations for cases of Microorganisms Similar
to Actinomyces (MSA), were included for this review (Fig-
ure 1).
3.1. Cases of Pelvic Actinomycosis Reported in Africa. From
the African continent, 3 articles of clinical cases were found,
totalling 8 clinical cases. The majority of patients were IUD
users; however in most cases the type of IUD used was
not disclosed. The pathology that was first diagnosed in
these cases was an ovarian tumour. The method of diagno-
sis that was utilised to definitively diagnose patients with
actinomycosis was histopathological reporting (Table 1). The
most common treatments were hysterectomy, laparotomy,
and antibiotic therapy. No follow-up data was presented.
3.2. Cases of Pelvic Actinomycosis Reported in Oceania. From
Oceania, 1 article was published that included 3 clinical cases
with the following ages: 56, 70, and 37 years; two of them
were copper IUD users. In the three cases, malignant lesions
were initially diagnosed; the final diagnosis was performed
postoperatively. Salpingo-oophorectomy along with antibi-
otic therapy was used in all the cases; patients fully recovered
after treatment. (Table 2).
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3.3. Cases of Pelvic Actinomycosis Reported in Asia. Fourteen
articles of 16 clinical cases came from Asia, the age of the
patients ranged between 25 and 86 years, and the average age
was 45.6 years (SD 15.5). The majority of patients were IUD
users, with a usage time of 1 year to more than 20 years; most
of the studies did not specify the type of IUD used. However,
cases in nonusers were also reported, despite the well-known
relationship between IUD use and pelvic actinomycosis. The
most commonpresumptive diagnosticwasmalignant lesions,
while, in other cases, Crohn’s disease and acute peritonitis
were also suspected. The most utilised diagnostic method
was histological reporting after surgical interventions, which
were invasive in most cases, such as hysterectomy and
salpingo-oophorectomy along with antibiotic therapy. Most
of the patients had a full recovery or at least a significant
improvement after follow-up; only a case of renal sequelae
was reported. (Table 3).
3.4. Cases of Pelvic Actinomycosis Reported in Europe. Twenty
clinical case report articles including 39 cases of pelvic
actinomycosis originated from Europe, in which ages ranged
from 18 to 65 years; average age was 40 years (SD 10.4). The
cases principally included female IUD users, with a usage
time ranging from 1.5 to 20 years; copper and multiload IUD
were the most reported; however in most studies the type of
IUD is not specified.The predominant presumptive diagnosis
was malignant lesion; other suspected diagnoses included
Crohn’s disease, acute appendicitis, endometrial infection,
pelvic inflammatory disease, and abscesses. Postoperative
histopathological reports were the most common definitive
diagnostic methods. Other methods of final diagnosis have
also been reported, such as the Pap smear, culture, API 20A
biochemical assays, and 16S rRNA sequencing techniques.
The most common treatments used were damaged tissue
excision, laparotomy, and salpingo-oophorectomy together
with antibiotic therapy. The majority of the articles do not
have follow-up information, nonetheless studies reporting
patient follow-up stated that they fully recovered after treat-
ment, and there is one report of death (Table 4).
3.5. Cases of Pelvic Actinomycosis Reported in America. With
regard to America, 16 articles with reports of 20 clinical cases
exist. The ages of patients ranged between 18 and 58 years
with an average age of 39.6 years (SD 9.9). All patients were
IUD users except one case, and the time of device use ranged
from 22 months to 33 years. Reported types of IUD include
Dalkon Shield and Lippes loop. Tubo-ovarian and pelvic
abscesses along with malignant lesions were the conditions
with the greatest diagnostic confusion. Similar to the other
summaries, the postsurgical histological reports were the
most reported definitive diagnostic methods. Other methods
were also utilised, such as culture, the 16S rRNA sequencing
technique, haematoxylin-eosin staining microscopy (HE),
and the IUD smear. Salpingo-oophorectomy and laparotomy
along with prolonged antibiotic therapy were the most used
therapeutic measures. After treatment most of the patients
had a full or significant recovery. (Table 5).
3.6. Cross-Sectional Studies. Eight cross-sectional studies of
reports worldwide that examine populations for cases of
actinomycosis or MSA were analysed. The prevalence of
pelvic actinomycosis was low. Likewise, there is a strong
relationship between the use of an IUD and the presence of
MSA. In this type of report, the diagnosis methods reviewed
were the Pap reports. However, it is important to emphasise
that what is reported in these analyses are MSA. Only 3
articles reported actinomycosis as such, and only one report
completely identified the causal agent through culture and
biochemical assays (Table 6).
4. Discussion
According to the analysis of the articles presented, Europe
was the continent on which the greatest number of cases
of pelvic actinomycosis was reported, followed by Asia and
America. However, it is important to emphasise that this
summary of information only gives us an approximation of
the real epidemiology of this disease, as the cases presented
in this article are only those reported. The youngest cases (18
years) are found in the European and American continents,
and the oldest case (86 years) is found in the Asian continent.
Actinomycosis is an invasive infection that frequently
imitates malignant processes in various anatomical zones.
Pelvic actinomycosis involves one of the regions that is most
often a source of diagnostic confusion. In this review, it is
evident that, in many of the cases presented, an erroneous
clinical diagnosis was made, confusing pelvic actinomycosis
mainly with malignant lesions. Other common suspects were
tubo-ovarian and pelvic abscesses and Crohn’s disease. As
such, as described by Kayikcioglu et al. [35] and Moniruddin
et al. [77], pelvic actinomycosis should be considered in the
differential diagnosis in any chronic inflammatory lesion of
the viscera located in the pelvic zone to prevent a diagnostic
error that could lead to unnecessary invasive treatment.
The diagnosis of pelvic actinomycosis is difficult because
it does not produce characteristic disease signs or symp-
toms. According to what was observed in this analysis, the
most utilised diagnostic method in all continents was the
histopathological report, which is commonly obtained after
a surgical intervention due to an initial diagnostic error.
This observation was also made by Purola and Paavonen
[78] and more recently by Pe´rez-Lo´pez et al. [73]. Other
highly reported methods are the Pap test, which is gener-
ally reliable, but not unequivocal, as Actinomyces could be
confused with similar organisms. Cases in which the causal
microorganism is completely identified are few, as are cases
identified by culture and biochemical assays. Valour et al.
[3] mentioned that culturing bacteria in anaerobic medium
is the cornerstone for diagnosing actinomycosis. However,
this method requires a very controlled and precise technique
and specific equipment. Identification by sequencing of the
16S rRNA segment is another technique that offers greater
precision. Currently other authors such as Demirezen et al.
[79] report the effectiveness of using specific primers to
identify themost commonActinomyces species frompatients’
swabs samples; this technique is more accurate and faster
than all the previous ones; the disadvantage is the high cost of
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reagents and the use of special equipment. However, because
of the nature of the pathology, there is no early diagnosis,
because, as has already been mentioned, the presence of
symptoms occurs in advanced stages of the disease.
According to the observed reports, we conclude that the
presentation of symptoms in pelvic actinomycosis is observed
in an advanced period of the pathology, which does not
include attack to the general state of health or fever, which is
oriented towards an infectious pathology.Themanifestations
found are occupationalmasses in the pelvic-abdominal cavity
that force the surgical procedures to be performed, and the
diagnosis is made up to the time of the histopathological
study.
Pelvic actinomycosis is considered to be a rare and
unusual disease, although the use of IUDs can promote its
appearance. In the articles analysed, the greatest number of
patients diagnosed with pelvic actinomycosis on all conti-
nents was IUD users, and the periods of use varied widely,
from one year to long periods, such as 33 years. However,
cases occurred mainly in users that wore IUDs for prolonged
periods. Thus, based on experience and observation, it is
recommended that IUDs be changed periodically to limit the
occurrence of this condition. Some authors, such as Valour et
al. [3], recommend changing the IUD every 5 years at a min-
imum, and others, such as Herna´ndez et al. [4], recommend
changes every 3 years. It should be emphasised that those
cases in which patients were not IUD users were identified
more recently. This observation could suggest that, despite
the information that is available regarding the relationship
between this condition and IUD use, the aetiology of pelvic
actinomycosis could be due to other factors.
Like all review studies, the main limitation of the study
was the lack of data reported, another limitation was that
not all articles were open access, and there were not enough
subscriptions to the respective journals to access them.
During the first reports of this disease, greater numbers
of cases were observed in developed countries, but, presently,
reports of cases in developing countries and regions such
as the Middle East, Southwest Asia, or Latin America are
more common. This change could be because, in the first
decades of its observation, this condition and its aetiology
were unknown and prevention was difficult. However, with
the advance of technology, preventative measures directed
at high-risk populations in developed countries began to be
applied, as opposed to developing countries, where no such
actions were taken.
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